Replies to post #25222 on US Stem Cell Inc (USRM)

[slickinvest]

USRM to da moon $$$

[Snug Harbour]

Key Stock Influences
Some key influences that might govern future stock price performance include:
• USRM is still a research and Development Company and its MyoCell product candidate has not received regulatory approval or generated any meaningful revenues and is not expected generate revenues over the near term. Therefore, any positive announcement related with approvals, outcome of ongoing trials, synergies due to partnership efforts could be a temporary trigger for stock performance.
• Over medium to longer term, successful launch & commercialization of existing and future therapeutics products would be critical given the considerable investments undertaken in R&D and infrastructure development during the recent past.
• Given high investments incurred related to the marketing of USRM’s products in different markets, cash drainage in its ongoing R&D activities and uncertainties related to the outcome of recent partnerships, overall return/profitability indicators could remain muted during the initial gestation period. Also, optimal utilization of integration with other global players will be among the key business sensitivities for the company.
• The company is likely to generate substantial net losses and negative cash flow from operations over the near to medium term. Therefore, USRM’s available cash balance might not be sufficient to fund its anticipated level of operations for at least the next twelve months. Therefore, timely arrangement of incremental funding would remain a critical liquidity & financial flexibility factor.

http://tradersnewssource.com/usrm-review/

[short_slayer]

Wow! Excellent exposure. IMO we will get news from the company or the FDA in short order. Go USRM!! $$